PV25 Speakers

Subject to change.

 

 

image

Cheng Cui, PhD

Sr. Director, AstraZeneca


Dr. Cheng Cui is a regulatory affairs expert with over ten years’ experience across the FDA and industry, specializing in digital health, biomarkers, and oncology diagnostics. At the FDA, he was lead reviewer for digital and computational pathology devices. At AstraZeneca, he leads translational regulatory strategy for AI/ML-enabled computational pathology and biomarkers to advance precision medicine in oncology.

Chat bot